tech
How Eli Lilly Became a $1 Trillion Company
Mounjaro and Zepbound turned Eli Lilly into a trillion-dollar pharmaceutical giant. But every blockbuster eventually faces competition– here's what Lilly is doing to avoid the boom-and-bust cycle that has humbled pharma giants in the past. (Source: Bloomberg)
Read full story on Bloomberg Tech → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Tech alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop